Cannabis companies are getting larger by the minute all thanks to the legalization in the U.S. and other parts of the world. They are offering a wide range of products aside from CBD oils, which are one of the most popular items to hit the market. The variety of choices just means that cannabis is beneficial, effective and a versatile alternative form of calming medicine. Here are some CBD stocks that are worth investing in.
For your skin
Saavy Naturals makes food-grade skincare products. The founders are former professional chefs, so they know what they are doing. Food-grade products are clean, organic products that are safe to consume and apply on the skin. In fact, Saavy Naturals was even featured on the hit reality show “Shark Tank” because of its massive potential, and Walmart has also taken interest in Saavy Naturals Everyday Bath Bombs products.
The company is a subsidiary of Trimax Corporation (OTCMKTS:TMXN), which specializes in mining exploration and development. Trimax and Saavy Naturals offer different products for men and women that contain hemp derivatives such as Bay Rum & Hemp Body Wash with moringa oil, Revitalizing Conditioner – Bay Rum & Hemp with quinoa protein, and Bay Rum & Hemp Body Cream with shea butter, among others. If they sound yummy and healthy, it may be a sign it is good for you. The recent surge in the stock market proves this for Trimax. Its stock price is at $0.0194 with a market valuation of 2.11 percent and its current market cap is at $6.5 million.
Trimax intends to fully enter into the cannabis industry with 100 percent acquisition of Recreational Dispensaries, which acts as a platform where cannabis enthusiasts can choose the best strains, order it online, and have it delivered straight to their homes. Imagine how the stock of Trimax will perform once more states in the U.S. legalize marijuana.
For your furry friends
Even your dogs and cats can benefit from cannabis products. However, controlled dosage according to their size and weight and recommendation from a veterinary doctor is still required.
PotNetwork Holding, Inc. (OTCMKTS:POTN) is a global leader in the cannabis industry. It owns Diamond CBD, which produces CBD products for pets. They offer 100 percent safe products with organic hemp derivatives. Some of their best sellers which help your dog or cat control their aggression and improve cognitive problems and urination/marking problems are Pet CBD Food and Medipets.
PotNetwork Holding’s future remains bright after it announced that Diamond CBD has already surpassed the $3 million mark when it comes to sales in the first 45 days of 2018. This represents a 300 percent increase compared to the same period last year. The future outlook remains upbeat for the company because, in the first two months of 2018, it has already reached record monthly sales. This prompted experts to get excited what the rest of 2018 holds for PotNetwork.
CBD oils and other derivatives
Aside from CBD oils for pets, Diamond CBD also offers edibles, vapes, creams, and grinders. It has collaborated with NFL Hall of Famer Lawrence Taylor to launch Lawrence Taylor Pain Master CBD Cream and with actor and comedian Tommy Chong for its Chong’s Choice product line, which features CBD-infused gummy bears, CBD oil vaping pen, and CBD-infused watermelon candy.
Companies also worth mentioning are Global Payout Inc. (OTC: GOHE), GB Sciences Inc. (OTCQB: GBLX) and Canopy Growth Corp (OTCMKTS:TWMJF). Global Payout recently traded over 28.1 million shares last year. It recently signed a deal with GreenRush Group, Inc. which will help the company achieve its expansion in the cannabis industry. On the other hand, GB Sciences announced late in 2017 that all their mother plants are products tissue propagation initiative. This means the company can control the quality and quantity of high crop yields every month. Lastly, Canopy Growth recently became the first pot company from Canada to list on the stock exchange and CEO Bruce Linton is preparing to join NASDAQ in the near future.
These cannabis companies prove that there is real money that can be made in the cannabis industry. They are all working hard to dispel the negative stigma surrounding marijuana and its derivatives. With the business booming and reaching record sales this year, expect them to break more sale records in 2018.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
Sono Motors introduces community advisory board
Sono Motors unveiled the latest prototype of its electric minivan with solar cells in the body. In parallel with the...
Ysios Capital invests 30 million in 2020 and plans to enter four companies in 2021
In a year marked by the COVID-19 pandemic, the venture capital manager Ysios Capital carried out six follow-on operations and...
Oxxo enters the fintech ecosystem with its digital wallet Spin
On March 2nd, Oxxo presented Spin, a digital wallet through which it will be possible to manage, send and receive...
AEDESEO asks for €57,000 in crowdfunding to research a new treatment
AEDESO wants to start a clinical study and launched a crowdfunding campaign to raise the necessary money for it. Patients...
Mainz-based biotech company ActiTrexx receives €3.5 million in financing
The biotech company ActiTrexx has recently closed a Series A financing round, during which it raised $4.2 million (€3.5 million)....
Biotech6 days ago
VB Devices closes a €1.1 million round to consolidate its market entry
Business6 days ago
The multifaceted benefits of Augmented and Virtual Reality in education
Featured6 days ago
ARisk, the startup of predictive risk algorithms, closes €350,000 round
Cannabis5 days ago
Legalization trend drives cannabis ETFs to significantly grow